tiprankstipranks
Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI

Karyopharm Therapeutics (KPTI) Similar Stocks

Compare
1,175 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Karyopharm Therapeutics
$4.35
$47.13M
-79.14%
5 Buy
1 Hold
0 Sell
Strong Buy
Neurocrine
$114.00
$11.37B
34.64
-19.24%
17 Buy
5 Hold
0 Sell
Strong Buy
Vertex Pharmaceuticals
$502.55
$129.05B
20.10%
15 Buy
10 Hold
1 Sell
Moderate Buy
Sarepta Therapeutics
$71.81
$6.97B
30.13
-44.01%
17 Buy
2 Hold
1 Sell
Strong Buy
Bluebird Bio
$3.79
$36.53M
-85.20%
1 Buy
5 Hold
0 Sell
Hold
Blueprint Medicines
$89.73
$5.95B
-5.41%
14 Buy
4 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KPTI
Karyopharm Therapeutics
4.35
-18.30
-80.79%
NBIX
Neurocrine
114.00
-23.92
-17.34%
VRTX
Vertex Pharmaceuticals
502.55
84.54
20.22%
SRPT
Sarepta Therapeutics
71.81
-57.65
-44.53%
BLUE
Bluebird Bio
3.79
-21.81
-85.20%
BPMC
Blueprint Medicines
89.73
-5.13
-5.41%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis